v3.24.2.u1
Stockholders’ Equity - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 02, 2023
provider
$ / shares
shares
Apr. 06, 2021
USD ($)
shares
Apr. 01, 2021
Apr. 30, 2021
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Dec. 31, 2023
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Accelerated cost | $             $ 195,100      
Period for recognition               1 year 3 months 18 days    
Common stock, shares authorized (in shares)         1,000,000,000     1,000,000,000   1,000,000,000
Granted (in shares)               0    
Unrecognized share-based compensation expense | $         $ 102,700     $ 102,700    
Common stock, shares issued (in shares)         119,479,134     119,479,134   118,216,979
Common stock, par value (in dollars per share) | $ / shares $ 0.01       $ 0.01     $ 0.01   $ 0.01
Share based payment expense | $         $ 14,391 $ 9,247   $ 26,295 $ 14,628  
Novant Health, Inc | Equity Alignment Agreement                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award percentage of total common stock issued and outstanding (up to) 19.90%                  
Equity alignment agreement will renew period 4 years                  
Agreement Condition One | Equity Alignment Agreement | Affiliated Entity | Privia Medical Group Tennessee, PLLC                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of providers | provider 1,000                  
Agreement Condition One | Novant Health, Inc | Equity Alignment Agreement                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares issued in transaction (in shares) 745,712                  
Agreement Condition Two | Novant Health, Inc | Equity Alignment Agreement                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares issued in transaction (in shares) 372,856                  
Agreement Condition Three | Equity Alignment Agreement | Affiliated Entity | Privia Medical Group Tennessee, PLLC                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of providers | provider 1,000                  
Agreement Condition Three | Novant Health, Inc | Equity Alignment Agreement                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares issued in transaction (in shares) 745,712                  
Omnibus Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock, shares authorized (in shares)   10,278,581                
Award percentage increase   5.00%                
Options grant price percent of fair market value of company stock price (at least)   100.00%                
2021 ESPP                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award percentage of total common stock issued and outstanding (up to)       1.00%            
Number of shares authorized (in shares)       10,278,581            
Shares reserved for issuance (in shares)         1,027,858     1,027,858    
Common stock, shares issued (in shares)         0     0    
Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Accelerated vesting, percent     100.00%              
At IPO                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Accelerated vesting, percent     60.00%              
12months after IPO                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Accelerated vesting, percent     20.00%              
Accelerated vesting, period     12 months              
18 months after IPO                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Accelerated vesting, percent     20.00%              
Accelerated vesting, period     18 months              
Options                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Period of acceleration     1 year              
Options, cost not yet recognized | $             $ 89,900      
Period for recognition             18 months      
Options | Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Period of acceleration     4 months              
Restricted Stock Units (RSUs)                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares)               2,149,616    
Restricted Stock Units (RSUs) | Omnibus Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares)   1,183,871                
Granted (in shares)   3,683,217                
Unrecognized share-based compensation expense | $   $ 62,300                
Award vesting period   4 years